Key Dates

Related Announcements

• February 28, 2024 - Notice of Correction of Expiration Date in PAR-21-166 and NOT-CA-24-025. See Notice NOT-CA-24-036
• March 25, 2021 - Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed). See NOFO PAR-21-166.

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to extend the expiration date for PAR-21-166, Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)". Therefore, with the addition/extension by one Application Due Date, PAR-21-166 now expires on August 8, 2024.

The following sections in Part 1. Overview Information, Key Dates section have been changed:  
Currently, Reads:

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date: May 08, 2024

Modified to Read (in bold italics):

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date: September 08, 2024

All other aspects of PAR-21-166 remain unchanged.
 

Inquiries

Please direct all inquiries to:

Miguel R. Ossandon, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5714
Email: [email protected]